Literature DB >> 7587704

A model for evaluation of in situ hybridization spot-count distributions in tissue sections.

M M Pahlplatz1, P C de Wilde, P Poddighe, H van Dekken, G P Vooijs, A G Hanselaar.   

Abstract

The interpretation of in situ hybridization (ISH) spot-count distributions, obtained from evaluation of ISH signals in tissue sections, is complicated by the unknown impact of nuclear truncation and of the localization of ISH spots within the nuclei. In this study, a mathematical model was developed to investigate the effects of nuclear truncation and of the distribution of ISH spots within the nucleus on the ISH spot-count distribution in tissue sections. In this model, it was assumed that nuclei are spherical and of constant diameter and that ISH spots have negligible size and are distributed randomly within the nucleus ("volume model") or along the nuclear membrane ("surface model"). A minimal nuclear profile diameter was introduced in order to study the effect of rejecting small nuclear fragments for spot-count evaluation. Given the section thickness, the nuclear size, the minimal nuclear profile diameter, and the true number of ISH spots per nucleus and their spatial distribution within the nucleus, the model predicts the proportion of nuclei observable in the section with a specific number of ISH spots. A program that performs the model calculations was developed for PC and is available upon request. For section thickness greater than 50% of the nuclear diameter, the main effect of increasing section thickness on spot-count distributions was the increase of the proportion of nuclei with the true chromosome copy number of spots. For lower section thickness, the total distribution shifted towards lower spot frequencies. The influence of the minimal profile diameter was most notable for values close to the nuclear diameter. The effect of the localization of ISH spots within the nucleus was shown to be prominent, especially for sections with thickness smaller than the nuclear diameter. Good correspondence between model-predicted distributions and measured distributions was obtained using the volume model and taking into account only large nuclear profiles.

Mesh:

Year:  1995        PMID: 7587704     DOI: 10.1002/cyto.990200302

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  6 in total

1.  Interphase cytogenetic analysis of cervical intraepithelial neoplasia.

Authors:  J Bulten; P J Poddighe; J C Robben; J H Gemmink; P C de Wilde; A G Hanselaar
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

2.  Quantitative analysis of numerical chromosome aberrations in various morphological types of colorectal carcinomas.

Authors:  A Nanashima; Y Tagawa; M Morinaga; H Kusano; T Nakagoe; H Ayabe
Journal:  J Gastroenterol       Date:  1996-12       Impact factor: 7.527

3.  Amplification patterns of three genomic regions predict distant recurrence in breast carcinoma.

Authors:  Lisa M Davis; Cole Harris; Lei Tang; Patti Doherty; Peter Hraber; Yumiko Sakai; Therese Bocklage; Katie Doeden; Bryan Hall; John Alsobrook; Ian Rabinowitz; Thomas M Williams; John Hozier
Journal:  J Mol Diagn       Date:  2007-07       Impact factor: 5.568

Review 4.  Use of multicolor fluorescence in situ hybridization to detect deletions in clinical tissue sections.

Authors:  Maisa Yoshimoto; Olga Ludkovski; Jennifer Good; Ciro Pereira; Robert J Gooding; Jean McGowan-Jordan; Alexander Boag; Andrew Evans; Ming-Sound Tsao; Paulo Nuin; Jeremy A Squire
Journal:  Lab Invest       Date:  2018-01-16       Impact factor: 5.662

5.  Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?

Authors:  J M Bartlett; A D Watters; S A Ballantyne; J J Going; K M Grigor; T G Cooke
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

Review 6.  Gain of Chromosomal Region 3q26 as a Prognostic Biomarker for High-Grade Cervical Intraepithelial Neoplasia: Literature Overview and Pilot Study.

Authors:  Margot M Koeneman; Irene T Ovestad; Emiel A M Janssen; Monique Ummelen; Roy F P M Kruitwagen; Anton H Hopman; Arnold J Kruse
Journal:  Pathol Oncol Res       Date:  2018-10-25       Impact factor: 3.201

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.